Report overview
Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.
This report contains market size and forecasts of Conjugate Vaccines in global, including the following market information:
Global Conjugate Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Conjugate Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Conjugate Vaccines companies in 2021 (%)
The global Conjugate Vaccines market was valued at 11890 million in 2021 and is projected to reach US$ 16960 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Conjugate Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Conjugate Vaccines include Novartis, Neuron Biotech, Serum Institute of India, Pfizer, Sanofi Pasteur, Bharat Biotech, Biological, GlaxoSmithKline and Merck and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Conjugate Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Conjugate Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Conjugate Vaccines Market Segment Percentages, by Type, 2021 (%)
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
Global Conjugate Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Conjugate Vaccines Market Segment Percentages, by Application, 2021 (%)
Children
Adults
Global Conjugate Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Conjugate Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Conjugate Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Conjugate Vaccines revenues share in global market, 2021 (%)
Key companies Conjugate Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Conjugate Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL
